Laryngeal Squamous Cell Carcinoma
18 clinical trials · Condition
◉ Watch Laryngeal Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer (NCT04030455) | M.D. Anderson Cancer Center | 2019-08-07 |
| Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin (NCT03258554) | National Cancer Institute (NCI) | 2018-04-03 |
| Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery (NCT02734537) | ECOG-ACRIN Cancer Research Group | 2016-11-23 |
| Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy (NCT02582008) | Wake Forest University Health Sciences | 2016-01-01 |
| A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck Cancer (NCT01314755) | Terrence Jones | 2003-11-01 |
Track Laryngeal Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.